SEARCH

SEARCH BY CITATION

References

  • 1
    Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A. Meningeal tumours. In: Loius DN, Ohgaki H, Wiestler OD, Cavenee WK., eds. WHO classification of tumours of the central nervous system. Lyon: International Agency for Research on Cancer, 2007. 16386.
  • 2
    Hatiboglu MA, Cosar M, Iplikcioglu AC, Ozcan D. Sex steroid and epidermal growth factor profile of giant meningiomas associated with pregnancy. Surg Neurol 2008; 69: 35662.
  • 3
    Smith JS, Quinones-Hinojosa A, Harmon-Smith M, Bollen AW, McDermott MW. Sex steroid and growth factor profile of a meningioma associated with pregnancy. Can J Neurol Sci 2005; 32: 1227.
  • 4
    Schlehofer B, Blettner M, Wahrendorf J. Association between brain tumors and menopausal status. J Natl Cancer Inst 1992; 84: 13469.
  • 5
    Custer B, Longstreth WT, Phillips LE, Koepsell TD, Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case–control study. BMC Cancer 2006; 6: 152.
  • 6
    The Medicines and Healthcare Products Regulatory Agency (MHRA). Hormone-replacement therapy: safety update, A UK Public Assessment Report, MHRA, London, 2007.
  • 7
    Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Sex steroid hormone exposures and risk for meningioma. J Neurosurg 2003; 99: 84853.
  • 8
    Navarro Silvera SA, Miller AB, Rohan TE. Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 2006; 118: 13214.
  • 9
    Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, Davis-King KE, Carreón T, Waters MA, Butler MA, Calvert GM, Schulte PA, Zivkovich Z, et al. Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 2004; 13: 15838.
  • 10
    Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, Rice T, Wrensch M. Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 2009; 20: 8796.
  • 11
    Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 2005; 114: 797805.
  • 12
    Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, Feychting M. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 2006; 164: 62936.
  • 13
    Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 2008; 26: 27982.
  • 14
    Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson B. Spinal meningiomas in women in Los Angeles county: investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev 1995; 4: 3339.
  • 15
    Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F. Association of meningioma with reproductive factors. Int J Cancer 2006; 119: 11527.
  • 16
    Beral V. The Million Women Study: design and characteristics of the study population. Breast Cancer Res 1999; 1: 7380.
  • 17
    World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization, 1992.
  • 18
    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 2002; 288: 32133.
  • 19
    Watson J, Wise L, Green J. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 2007; 63: 8439.
  • 20
    Townsend P, Phillimore P, Beattie A. Health and deprivation: inequality and the North. London: Croom Helm, 1988.
  • 21
    Benson VS, Pirie K, Green J, Casabonne D, Beral V. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 2008; 99: 18590.
  • 22
    Beral V, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007; 369: 170310.
  • 23
    Wigertz A, Lönn S, Hall P, Auvinen A, Christensen H, Johansen C, Klæboe K, Salminen T, Schoemaker M, Swerdlow A, Tynes T, Feychting M. Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 2008; 17: 266370.
  • 24
    Sanson M, Cornu P. Biology of meningiomas. Acta Neurochir 2000; 142: 493505.
  • 25
    Poisson M, Pertuiset BF, Hauw JJ. Steroid hormone receptors in human meningiomas, gliomas and brain metastases. J Neurooncol 1983; 1: 17989.
  • 26
    Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, Van Duijnhoven MWF, Thijssen JHH. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 2000; 65: 795800.
  • 27
    Banks E, Beral V, Cameron R, Hogg A, Langlet N, Barnes I, Bull D, Elliman J, Harris CH. Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat 2001; 6: 35763.